RECRUITING

Rural Alliance for Diabetes Prevention

Talk to us

Conditions

PreDiabetesDiabetes Prevention ProgramHbA1cPhysical ActivityWeight Loss

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this randomized controlled trial is to compare the effectiveness of Cooperative Extension implementing two delivery methods (group video vs. self-directed) and participant recruitment strategies of the National Diabetes Prevention Program (NDPP) to adults in rural communities. Exploratory assessments of implementation facilitators and barriers will be completed to determine strategies that may impact intervention effectiveness and that may support or impede the implementation, dissemination, and effectiveness of Cooperative Extension to deliver the NDPP to prediabetic adults in rural areas.

Official Title

Rural Alliance for Diabetes Prevention

Quick Facts

Study Start:2024-07-30
Study Completion:2028-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06252038

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or older
  2. * BMI ≥25 kg/m2, ≥23 kg/m2 if Asian
  3. * Blood test results in the pre diabetic range within the last year (HbA1C = 5.7%-6.4% or fasting plasma glucose= 100-125 mg/dl or 2-hr. plasma glucose following a 75-gm glucose load = 140-199 mg/dL) or have previous diagnosis of gestational diabetes or a positive screening for pre diabetes based on CDC pre diabetes risk test
  4. * Willing to travel to KSRE site for orientation and outcome testing
  5. * Available to attend pre-specified meeting time of GV for their respective KSRE location
  6. * Medically stable as deemed by primary care provider consent
  7. * English speaking
  1. * Previous diagnosis of Type I or II diabetes
  2. * Taking FDA-approved weight loss medications
  3. * Primary care provider stating that patient should not participate
  4. * Self-report as currently pregnant or within 6 weeks of having given birth (or planning to become pregnant in the next 12 months)
  5. * Unable to engage in physical activity

Contacts and Locations

Study Contact

Annie Rice, M.S.
CONTACT
785-764-3770
arice7@kumc.edu

Principal Investigator

Anna M Gorczyca, PhD
PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center

Study Locations (Sites)

University of Kansas Medical Center
Kansas City, Kansas, 66160
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • Anna M Gorczyca, PhD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-30
Study Completion Date2028-05-31

Study Record Updates

Study Start Date2024-07-30
Study Completion Date2028-05-31

Terms related to this study

Keywords Provided by Researchers

  • Diabetes Prevention Program
  • HbA1c
  • Physical Activity
  • Weight Loss

Additional Relevant MeSH Terms

  • PreDiabetes